Covid-19 drug approval à la Pfizer – what doesn’t fit will be made right!
#Blotgate, a new dimension of intentional fraud
In the inflationary flood of reports about the criminal activities, in the context of the production and use of the experimental gene therapy injections with the recombinant genetically engineered Covid-19 active ingredients (“SARS-CoV-2 or Corona vaccination”, see [A]). a remarkable article [1] by investigative UK journalist Sonja Elijha [2] almost went under. The meticulous research results of the former BBC researcher could well have the potential to be a game changer in the legal investigation and conviction of those responsible for what is probably the largest scientific fraud and medical scandal in human history. Elijah’s publication is being discussed in detail and peer-reviewed in relevant specialist circles under the keyword #blotgate [3].
Elijah had already made enormous contributions to the analysis of the leaked Pfizer documents and correspondence relating to the telescoped clinical trial phases [4]. She carried out exactly those tests that are actually intended for the specialist departments of the regulatory authorities at the EMA (European Medicines Agency) and FDA (US Food and Drug Administration). According to current knowledge, these authorities, as well as at the national level in accordance with Section 22 AMG (Medicines Act), the BfARM (Federal Institute for Drugs and Medical Devices), PEI (Paul Ehrlich Institute) and IQWiG (Institute for Quality and Efficiency in Health Care), as well as the Peer review processes in the relevant scientific journals [5] have failed completely across the board. Such a structural failure cannot be explained as fraud either through negligence or coincidence, but rather only through deliberate, deliberate collusion. This is not at all surprising given that we are entering the age of third-party dependence and the disastrous public-private partnership. These fundamental changes in previously independent and tax-funded research have turned what were once largely neutral and objective scientific institutions into contract research institutes, industrial corruption and favoritism. This also made it possible for the pharmaceutical industry to essentially finance the regulatory authorities that it is supposed to control [6]. At the EMA, immediately before the first conditional Covid-19 drug approval was granted in December 2020, they even managed to place a pharmaceutical lobbyist (Emer Cooke) as president of this institution in November 2020 [7], a rogue who thinks evil of it .
A brief recapitulation of what has been determined so far makes it easier to understand the complex molecular biological instrumental analytical connections that underlie Elijah’s new investigation results.
Already in January 2021, the cell biologist Dr. Vanessa Schmidt-Krüger analyzed the EMA Open Assessment Report on Corminaty (the Pfizer/BioNTech Covid-19 gene therapy “vaccine”) [8, 34]. A key point of their criticism concerned the complete lack of clarity of the end product composition from large-scale industrial production, which the EMA auditors also noticed. The decisive factor was the finding that, in contrast to the documentation of modRNA integrity (a measure of purity that indicates how much completely intact modRNA is contained in the samples), on a laboratory scale in clinical studies it was 78%, in contrast to 55% in industrial mass production. The intact modRNA is characterized by an initial so-called 5′ cap structure, the coding nucleotide sequence for the protein to be translated (in this case the SARS-CoV-2 spike protein) and a so-called final 3′ poly-A tail. In addition, the original SARS-CoV-2 mRNA (messenger RNA [9]) in the active ingredient (tozinameran) from Comirnaty was modified by replacing the nucleic base uracil with pseudouridine (hence modRNA [10]) in order to reduce the reactogenicity. The coding sequence contains a membrane anchor protein, which prevents the formation of free spike proteins circulating in the cardiovascular system, as well as a lock protein (2P Lock), which is intended to prevent the cleavage (at the so-called furin cleavage site) and opening of the binding sites of the S1 subunit [ 11]. Both of the latter modifications have now proven to be ineffective, meaning that the freely circulating spike proteins from the Pfizer poison cocktail can fully develop their known toxic properties in the organism. The reduced modRNA integrity criticized by the EMA auditors poses enormous risk potential for patients. A differentiated analysis of the brew from the Pfizer pharmaceutical kettles revealed fragmented (so-called truncated s.a. [1(a), 3] #humpgate) modRNA, of which no one knows what kind of foreign proteins it might express, residual components of linearized DNA and various enzymes from the modRNA synthesis process, as well as other microbiological contaminants [B]. It is also questionable to what extent the minimized active ingredient content can still achieve the postulated effect (immune reaction and antibody formation). The EMA examiners have at least asked a key question that should have been conclusively answered in advance in the approval documents. In this respect, the experimental, documented evidence requested by the EMA for end product verification, including through so-called Western blot analysis [12], is of essential importance for consumer safety.
